tetradecanoylphorbol acetate has been researched along with Leukemia, Myelomonocytic, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banaszak, LG; Gao, SG; Gutierrez-Rodrigues, F; Kajigaya, S; Keyvanfar, K; Quinones Raffo, D; Wu, ZJ; Young, NS; Zhao, X | 1 |
| Fung, MC; Hapel, AJ; Leung, KN; Mak, NK | 1 |
| Dang, Y; Edwards, SW; Galvani, DW; Lowe, GM | 1 |
| Acs, G; Banerjee, R; Bekesi, JG; Choi, HS; Deak, G; Holland, JF; Paronetto, F; Sperber, K; Tarcsafalvi, A | 1 |
| Brown, C; Kraft, A; Lilly, M; Pettit, G | 1 |
| Hayashi, M; Hino, K; Honma, Y; Hozumi, M; Okabe-Kado, J; Sakurai, M; Sampi, K; Tsuruoka, N | 1 |
6 other study(ies) available for tetradecanoylphorbol acetate and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
CRISPR/Cas9-mediated ASXL1 mutations in U937 cells disrupt myeloid differentiation.
Topics: Cell Cycle; Cell Differentiation; Cell Proliferation; CRISPR-Cas Systems; Fluorouracil; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Chronic; Mutation; Repressor Proteins; Tetradecanoylphorbol Acetate; Transcriptome; U937 Cells | 2018 |
Monocytic differentiation of a myelomonocytic leukemic cell (WEHI 3B JCS) is induced by tumour necrosis factor-alpha (TNF-alpha).
Topics: Animals; Antigens, Differentiation, Myelomonocytic; Cell Differentiation; Cell Division; Clone Cells; Granulocyte Colony-Stimulating Factor; In Vitro Techniques; Interferon-gamma; Leukemia, Myelomonocytic, Chronic; Mice; Monocytes; Phagocytosis; Recombinant Proteins; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1993 |
The effects of GM-CSF on myeloperoxidase release in normal and myelodysplastic neutrophils.
Topics: Anemia; Cytochalasin B; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Kinetics; Leukemia, Myelomonocytic, Chronic; Luminescent Measurements; Myelodysplastic Syndromes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peroxidase; Recombinant Proteins; Reference Values; Superoxides; Tetradecanoylphorbol Acetate | 1993 |
Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Aged; Animals; Antigens, CD; Blotting, Northern; HIV-1; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Chronic; Male; Mice; Mice, Nude; Microscopy, Electron; Myelodysplastic Syndromes; Neoplasm Transplantation; Plasmids; Protein Kinase C; Proviruses; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Virus Replication | 1992 |
Bryostatin 1: a potential anti-leukemic agent for chronic myelomonocytic leukemia.
Topics: Antineoplastic Agents; Bryostatins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lactones; Leukemia, Myelomonocytic, Chronic; Macrolides; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Tumor Stem Cell Assay | 1991 |
Induction of differentiation of mouse myeloid leukemia M1 cells by serum of patients with chronic myeloid leukemia.
Topics: Animals; Cell Differentiation; Culture Media; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Lymphokines; Macrophages; Mice; Phytohemagglutinins; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1988 |